Molecular Targets and Mechanisms of Radiosensitization Using DNA Damage Response Pathways
Open accessThe DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
The cellular reaction to genomic instability includes a network of signal transduction pathways collectively referred to as the DNA damage response (DDR). Activated by a variety of DNA lesions, the DDR orchestrates cell cycle arrest and DNA repair, and initiates apoptosis in instances where damage cannot be repaired. As such, disruption of the DDR increases the prevalence of DNA damage secondary to incomplete repair, and in doing so, enhances radiation-induced cytotoxicity. This article describes the molecular agents and their targets within DDR pathways that sensitize cells to radiation. Moreover, it reviews the therapeutic implications of these compounds, provides an overview of relevant clinical trials and offers a viewpoint on the evolution of the field in the years to come.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
ATM and ATR Substrate Analysis Reveals Extensive Protein Networks Responsive to DNA Damage
Matsuoka, S., Ballif, B. A., Smogorzewska, A., McDonald, E. R., Hurov, K. E., Luo, J., Bakalarski, C. E., Zhao, Z., Solimini, N., Lerenthal, Y., et al. (2007) · Science · doi:10.1126/science.1140321 · Cited by 3,075
Cell-cycle checkpoints and cancer
Kastan, M. B., & Bartek, J. (2004) · Nature · doi:10.1038/nature03097 · Cited by 2,836
Sensing DNA Damage Through ATRIP Recognition of RPA-ssDNA Complexes
Zou, L., & Elledge, S. J. (2003) · Science · doi:10.1126/science.1083430 · Cited by 2,693
Cell cycle checkpoint signaling through the ATM and ATR kinases
Abraham, R. T. (2001) · Genes & Development · doi:10.1101/gad.914401 · Cited by 1,966
The DNA Damage Response: Ten Years After
Harper, J. W., & Elledge, S. J. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.11.015 · Cited by 1,705
Synthesis and Function of 3-Phosphorylated Inositol Lipids
Vanhaesebroeck, B., Leevers, S. J., Ahmadi, K., Timms, J., Katso, R., Driscoll, P. C., Woscholski, R., Parker, P. J., & Waterfield, M. D. (2001) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.70.1.535 · Cited by 1,535
ATM Activation by DNA Double-Strand Breaks Through the Mre11-Rad50-Nbs1 Complex
Lee, J.-H., & Paull, T. T. (2005) · Science · doi:10.1126/science.1108297 · Cited by 1,424
Cyclin-Dependent Kinase Pathways As Targets for Cancer Treatment
Shapiro, G. I. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.7689 · Cited by 1,036
Cockayne syndrome: Review of 140 cases
Nance, M. A., & Berry, S. A. (1992) · American Journal of Medical Genetics · doi:10.1002/ajmg.1320420115 · Cited by 806
DNA damage checkpoints: from initiation to recovery or adaptation
Bartek, J., & Lukas, J. (2007) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2007.02.009 · Cited by 784
Buck, D., Malivert, L., de Chasseval, R., Barraud, A., Fondanèche, M.-C., Sanal, O., Plebani, A., Stéphan, J.-L., Hufnagel, M., le Deist, F., et al. (2006) · Cell · doi:10.1016/j.cell.2005.12.030 · Cited by 722
The Complexity of DNA Damage: Relevance to Biological Consequences
Ward, J. F. (1994) · International Journal of Radiation Biology · doi:10.1080/09553009414551401 · Cited by 633
Hirai, H., Iwasawa, Y., Okada, M., Arai, T., Nishibata, T., Kobayashi, M., Kimura, T., Kaneko, N., Ohtani, J., Yamanaka, K., et al. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0463 · Cited by 540
UCN-01: a potent abrogator of G2 checkpoint function in cancer cells with disrupted p53
Wang, Q., Fan, S., Eastman, A., Worland, P. J., Sausville, E. A., & O'Connor, P. M. (1996) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/88.14.956 · Cited by 453
Targeting NEDD8-Activated Cullin-RING Ligases for the Treatment of Cancer
Soucy, T. A., Smith, P. G., & Rolfe, M. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-0343 · Cited by 222
Syljuåsen, R. G., Sørensen, C. S., Nylandsted, J., Lukas, C., Lukas, J., & Bartek, J. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-2434 · Cited by 99
Research works printed but not linked: 137
- 10.1080/09553009014551251 · DOI · Paper page
- 10.1667/0033-7587(2001)156[0577:CAFDTS]2.0.CO;2 · DOI · Paper page
- 10.1016/S0079-6603(08)60611-X · DOI · Paper page
- 10.2307/3579807 · DOI · Paper page
- 10.1269/jrr.07123 · DOI · Paper page
- 10.1080/095530098142013 · DOI
- 10.1667/RR0628.1 · DOI
- 10.1158/1078-0432.CCR-06-1269 · DOI
- 10.1074/jbc.273.10.5858 · DOI · Paper page
- 10.1016/j.cell.2007.09.041 · DOI · Paper page
- 10.1016/j.cell.2008.12.041 · DOI · Paper page
- 10.1038/13821 · DOI · Paper page
- 10.1074/jbc.M513265200 · DOI · Paper page
- 10.1038/nsmb.1639 · DOI · Paper page
- 10.1126/science.1192912 · DOI · Paper page
- 10.4161/auto.19693 · DOI · Paper page
- Waldman T , KinzlerKW, VogelsteinB. p21 is necessary for the p53-mediated G1 arrest in human cancer cells.Cancer Res.55(22), 5187–5190 (1995).
- 10.1073/pnas.172382899 · DOI · Paper page
- 10.4161/cc.9.3.10556 · DOI · Paper page
- 10.1016/j.molcel.2006.03.017 · DOI
- 10.1126/science.1905840 · DOI · Paper page
- 10.1038/nrc1881 · DOI · Paper page
- 10.1016/j.dnarep.2010.09.011 · DOI · Paper page
- 10.1016/j.febslet.2011.04.002 · DOI
- 10.1016/j.molonc.2011.07.002 · DOI · Paper page
- 10.1083/jcb.201009074 · DOI
- 10.1158/1078-0432.CCR-06-2793 · DOI
- 10.1016/j.dnarep.2009.04.012 · DOI · Paper page
- 10.1016/S1535-6108(03)00110-7 · DOI · Paper page
- 10.1074/mcp.M700006-MCP200 · DOI
- 10.1158/0008-5472.CAN-06-3545 · DOI · Paper page
- 10.1038/nature05236 · DOI · Paper page
- 10.1080/02841860152619115 · DOI · Paper page
- 10.1002/humu.20501 · DOI · Paper page
- 10.1093/hmg/9.4.583 · DOI
- 10.1016/j.dnarep.2004.03.025 · DOI · Paper page
- 10.1016/j.ijrobp.2009.02.057 · DOI · Paper page
- 10.1016/j.dnarep.2004.04.009 · DOI · Paper page
- 10.1097/01.md.0000229482.27398.ad · DOI · Paper page
- 10.1093/hmg/7.10.1555 · DOI · Paper page
- 10.1016/S0065-230X(08)60095-0 · DOI · Paper page
- 10.1038/bjc.2011.266 · DOI
- 10.1093/jnci/dji141 · DOI · Paper page
- 10.1038/ng1837 · DOI · Paper page
- 10.1016/S0092-8674(00)80086-0 · DOI · Paper page
- 10.1101/gad.10.19.2411 · DOI · Paper page
- 10.1083/jcb.201204098 · DOI · Paper page
- 10.1083/jcb.201204035 · DOI · Paper page
- 10.2307/3573947 · doi:10.2307/3573947
- 10.1148/123.2.463 · DOI · Paper page
- 10.1148/123.2.475 · doi:10.1148/123.2.475
- 10.1615/CritRevEukarGeneExpr.v19.i3.50 · DOI
- 10.1093/annonc/mdf280 · DOI · Paper page
- 10.1006/bbrc.1997.6689 · doi:10.1006/bbrc.1997.6689
- 10.1667/0033-7587(2001)156[0095:TOMFTN]2.0.CO;2 · DOI
- 10.1002/jcp.10475 · DOI
- 10.1002/cyto.a.20955 · DOI
- 10.3748/wjg.v8.i5.797 · doi:10.3748/wjg.v8.i5.797
- 10.2307/3576199 · DOI
- 10.1038/nm1096-1140 · DOI
- Sarkaria JN , BusbyEC, TibbettsRSet al. Inhibition of ATM and ATR kinase activities by the radiosensitizing agent, caffeine. Cancer Research 59(17), 4375–4382 (1999).
- Price BD , YoumellMB. The phosphatidylinositol 3-kinase inhibitor wortmannin sensitizes murine fibroblasts and human tumor cells to radiation and blocks induction of p53 following DNA damage.Cancer Res.56(2), 246–250 (1996).
- Sarkaria JN , TibbettsRS, BusbyEC, KennedyAP, HillDE, AbrahamRT. Inhibition of phosphoinositide 3-kinase related kinases by the radiosensitizing agent wortmannin.Cancer Research58(19), 4375–4382 (1998).
- 10.1039/b405431h · DOI · Paper page
- 10.1016/S0021-9258(18)43839-2 · doi:10.1016/s0021-9258(18)43839-2
- 10.1074/jbc.M609603200 · DOI · Paper page
- 10.1016/S0021-9258(17)37680-9 · DOI · Paper page
- Rosenzweig KE , YoumellMB, PalayoorST, PriceBD. Radiosensitization of human tumor cells by the phosphatidylinositol3-kinase inhibitors wortmannin and LY294002 correlates with inhibition of DNA-dependent protein kinase and prolonged G2–M delay.Clin. Cancer Res.3(7), 1149–1156 (1997).
- Izzard RA , JacksonSP, SmithGC. Competitive and noncompetitive inhibition of the DNA-dependent protein kinase.Cancer Res.59(11), 2581–2586 (1999).
- 10.1016/j.ygyno.2007.08.073 · DOI
- 10.2174/1568011054866937 · DOI
- 10.1186/1756-9966-27-76 · DOI
- 10.1158/1535-7163.MCT-05-0192 · DOI
- 10.1158/1535-7163.MCT-09-0519 · DOI · Paper page
- 10.4161/cc.11.6.19576 · DOI
- 10.4161/cbt.21093 · DOI · Paper page
- 10.1038/bjc.2012.265 · DOI · Paper page
- 10.1038/bjc.2011.243 · DOI · Paper page
- 10.1038/sj.onc.1204942 · DOI · Paper page
- 10.1038/sj.neo.7900175 · DOI
- 10.1038/nature10760 · DOI · Paper page
- 10.1074/jbc.275.8.5600 · DOI · Paper page
- 10.1200/JCO.2001.19.8.2319 · DOI · Paper page
- 10.1200/JCO.2005.03.116 · DOI
- 10.1158/1078-0432.CCR-04-2602 · DOI
- 10.1093/annonc/mdj076 · DOI
- 10.1182/blood-2005-08-3351 · DOI · Paper page
- 10.1016/j.ymthe.2005.12.009 · DOI
- 10.1158/1078-0432.CCR-06-1424 · DOI · Paper page
- 10.4161/cc.8.8.8203 · DOI
- 10.1158/1078-0432.CCR-09-1029 · DOI · Paper page
- 10.1158/1535-7163.MCT-08-0492 · DOI · Paper page
- 10.1158/0008-5472.CAN-09-3573 · DOI · Paper page
- 10.1158/1535-7163.MCT-08-0662 · DOI
- 10.1158/1535-7163.MCT-07-2391 · DOI · Paper page
- 10.4161/cc.6.1.3699 · DOI
- 10.1158/1535-7163.MCT-06-0371 · DOI
- Kohn EA , YooCJ, EastmanA. The protein kinase C inhibitor Gö6976 is a potent inhibitor of DNA damage-induced S and G2 cell cycle checkpoints.Cancer Res.63(1), 31–35 (2003).
- 10.1074/jbc.M309054200 · DOI · Paper page
- 10.1158/1535-7163.MCT-11-0406 · DOI
- 10.1016/j.coph.2005.04.009 · DOI · Paper page
- 10.2174/187152006777698132 · DOI
- 10.1021/jm0495935 · DOI · Paper page
- 10.1158/1535-7163.MCT-06-0567 · DOI
- 10.1124/jpet.109.154997 · DOI
- 10.1158/0008-5472.CAN-10-1252 · DOI · Paper page
- 10.1093/emboj/cdf506 · DOI · Paper page
- 10.1016/S1535-6108(03)00053-9 · DOI · Paper page
- 10.1038/ng1232 · DOI · Paper page
- Senderowicz AM . Novel small molecule cyclin-dependent kinases modulators in human clinical trials.Cancer Biol. Ther.2(4 Suppl. 1), S84–S95 (2003).
- 10.1358/dnp.2010.23.7.1490760 · DOI
- Wang Y , LiJ, BooherRNet al. Radiosensitization of p53 mutant cells by PD0166285, a novel G(2) checkpoint abrogator. Cancer Res. 61(22), 8211–8217 (2001).
- 10.1053/jhep.2003.50112 · DOI · Paper page
- 10.1016/j.ccr.2010.08.011 · DOI · Paper page
- 10.1186/1471-2407-6-292 · DOI
- 10.4161/cbt.9.7.11115 · DOI · Paper page
- Schellens JH LeijenS ShapiroGIet al. A Phase I and pharmacological study of MK-1775 a Wee1 tyrosine kinase inhibitor in both monotherapy and in combination with gemcitabine cisplatin or carboplatin in patients with advanced solid tumors. Presented at: 2009 American Society of Clincal Oncology Annual Meeting Orlando FL USA 29 May–2 June 2009 (Abstract 3510). · doi:10.1200/jco.2009.27.15_suppl.3510
- 10.1186/1476-4598-8-34 · DOI
- 10.1093/carcin/bgi081 · DOI
- 10.1016/0167-8140(96)01806-3 · DOI · Paper page
- 10.1016/0959-8049(95)00622-2 · DOI
- 10.1007/s00109-007-0227-9 · DOI
- 10.1016/j.molcel.2011.09.026 · DOI
- 10.2174/092986707782360079 · DOI
- 10.1124/mol.108.050807 · DOI
- 10.1158/0008-5472.CAN-06-2181 · DOI · Paper page
- 10.1158/1078-0432.CCR-07-0632 · DOI
- 10.1158/1078-0432.CCR-08-1006 · DOI
- 10.1158/1078-0432.CCR-10-1927 · DOI · Paper page
- 10.1158/1078-0432.CCR-09-1592 · DOI
- 10.1074/jbc.M110.188425 · DOI
- 10.1158/0008-5472.CAN-08-4671 · DOI
- 10.1158/0008-5472.CAN-11-2866 · DOI · Paper page
- 10.1371/journal.pone.0034079 · DOI
- 10.1038/emboj.2008.127 · DOI
- 10.4161/cc.10.24.18661 · DOI
- 10.1002/ijc.27512 · DOI
Cited by
Liu, Y., Zheng, C., Huang, Y., He, M., Xu, W. W., & Li, B. (2021) · MedComm · doi:10.1002/mco2.55 · Cited by 387
Radiation-induced signaling pathways that promote cancer cell survival (Review)
HEIN, A. L., OUELLETTE, M. M., & YAN, Y. (2014) · International Journal of Oncology · doi:10.3892/ijo.2014.2614 · Cited by 201
“A DsB is repaired by one of two competing mechanisms: non-homologous end joining repair (NHEJ) and homologous recombination (HR) (10), with both mechanisms regulated by pIKKs.”
BackgroundFocus on UV-Induced DNA Damage and Repair—Disease Relevance and Protective Strategies
Kciuk, M., Marciniak, B., Mojzych, M., & Kontek, R. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21197264 · Cited by 168
“Furthermore, DNA-PKcs recruit Artemis endonuclease and phosphorylates DNA ligase IV, allowing the ligation of the broken ends [61].”
BackgroundInfluentialPal, S., Kozono, D., Yang, X., Fendler, W., Fitts, W., Ni, J., Alberta, J. A., Zhao, J., Liu, K. X., Bian, J., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-3691 · Cited by 101
Self-citationDDRprot: a database of DNA damage response-related proteins
Andrés-León, E., Cases, I., Arcas, A., & Rojas, A. M. (2016) · Database · doi:10.1093/database/baw123 · Cited by 12
“Due to its essential role in combating genome instability and therefore, its central influence on disease (3, 4), DDR pathways have been used as therapeutic targets (5), with molecules like PARP (Poly ADP-Ribose polymerase) inhibitors (6, 7) or more recently ATR (Ataxia telangiectasia and Rad3 related) inhibitors”
Background
Metadata
- Authors
- Raleigh, D. R., & Haas-Kogan, D. A.
- Venue
- Future Oncology
- Publisher
- Informa UK Limited
- Published
- 2013-02-15
- Volume
- 9
- Issue
- 2
- Pages
- 219-233
- ISSN
- 1479-6694 (ISSN-L)
- 1744-8301
- OpenAlex
- W2009215680
- Cited by
- 69
- References
- 16
- FWCI
- 2.29
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.